Chinese COVID-19 vaccine candidate appears safe, induces immune response; read details
Beijing: Results from an early-phase clinical trial of a Chinese vaccine candidate, CoronaVac, revealed that the formulation appears safe and ...
Read moreBeijing: Results from an early-phase clinical trial of a Chinese vaccine candidate, CoronaVac, revealed that the formulation appears safe and ...
Read moreNew Delhi: With the two mRNA vaccine candidates from pharma giants Pfizer-BioNTech and Moderna showing effectiveness in preventing Covid-19 in ...
Read moreLondon: Normalcy from the Covid era can only be expected by next year's winter as any Covid vaccine will take ...
Read moreKanpur: The first batch of Russia's Sputnik V vaccine for COVID-19 is likely to reach Kanpur's Ganesh Shankar Vidyarthi Medical ...
Read moreAligarh (Uttar Pradesh): More than 250 applications have been received for the trial of COVID-19 vaccine 'Covaxin' at the Jawaharlal ...
Read moreNew York: As the US was preparing for the final approval of COVID-19 vaccines and distribution, the politics behind it ...
Read moreNew York: Roughly 20 million people could be vaccinated against the coronavirus in December, the chief of the Donald Trump ...
Read moreNew Delhi: Adar Poonawalla, CEO and Owner of Serum Institute of India (SII) is putting $250 million of his family's ...
Read moreNew Delhi: The Russian 'Sputnik V' vaccine for Covid-19 has arrived in India following the nod to Pharma major Dr ...
Read moreCanberra: A COVID-19 vaccine in development by Australia's University of Queensland (UQ) was declared ready to progress to later-stage clinical ...
Read more